The role of the hedgehog signaling pathway in the development of basal cell carcinoma and opportunities for treatment

Clinical Cancer Research

Volumn 16, Issue 13, 2010, Pages 3335-3339

  Caro, Ivor ^a   Low, Jennifer A ^a  

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BMS 833923; CYCLOPAMINE; GDC 0449; SONIC HEDGEHOG PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BASAL CELL CARCINOMA; BASAL CELL NEVUS SYNDROME; CANCER THERAPY; CARCINOGENESIS; CLINICAL TRIAL; EMBRYO DEVELOPMENT; FATIGUE; HEART ATRIUM FIBRILLATION; HUMAN; HYPONATREMIA; MEDULLOBLASTOMA; MULTIPLE CANCER; MUSCLE SPASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION;

BASAL CELL NEVUS SYNDROME; CARCINOMA, BASAL CELL; HEDGEHOG PROTEINS; HUMANS; LIGANDS; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; SKIN NEOPLASMS;

EID: 77954227128     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-09-2570     Document Type: Article

References (26)

1. Ingham P, Placzek M. Orchestrating ontogenesis: variations on a theme by sonic hedgehog. Nat Rev Genet 2006;7:841-50.
2. Teglund S, Toftgård R. Hedgehog beyond medulloblastoma and basal cell carcinoma. Biochim Biophys Acta 2010;1805:181-208.
3. Rubin LL, de Sauvage FJ. Targeting the hedgehog pathway in cancer. Nat Rev Drug Discov 2006;5:1026-33.
4. Ruel L, Therond P. Variations in Hedgehog signaling: divergence and perpetuation in Sufu regulation of Gli. Genes Dev 2009;23:1843-8.
5. Chen M-H, Wilson CW, Li Y-J, et al. Cilium-independent regulation of Gli protein function by Sufu in Hedgehog signaling is evolutionarily conserved. Genes Dev 2009;23:1910-28.
6. Evangelista M, Tian H, de Sauvage FJ. The Hedgehog signaling pathway in cancer. Clin Cancer Res 2006;12:5924-8.
7. Gorlin RJ. Nevoid basal-cell carcinoma syndrome. Medicine (Baltimore) 1987;66:98-113.
8. Gailani MR, Bale DJ, Lefell JJ, et al. Developmental defects in Gorlin syndrome related to a putative tumor suppressor gene on chromosome 9. Cell 1992;69:111-7.
9. Hahn H, Wicking C, Zaphiropoulous PG, et al. Mutations of the Human Homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 1996;85:841-51.
10. Epstein EH. Basal cell carcinomas: attack of the hedgehog. Nat Rev Cancer 2008;8:743-54.
11. Scales SJ, deSauvage FJ. Mechanisms of hedgehog pathway activation in cancer and implications for therapy. Trends Pharmacol Sci 2008;30:303-12.
12. Rudin CM, Hann CL, Laterra J, et al. Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449. N Engl J Med 2009;361:1173-8.
13. Lee Y, Miller HL, Jensen P, et al. A molecular fingerprint for medulloblastoma. Cancer Res 2003;63:5428-37.
14. Yauch RL, Gould SE, Scales SJ, et al. A paracrine requirement for hedgehog signalling in cancer. Nature 2008;455:406-10.
15. Tian H, Callahan CA, DuPree KJ, et al. Hedgehog signaling is restricted to the stromal compartment during pancreatic carcinogenensis. Proc Natl Acad Sci U S A 2009;106:4254-8.
16. Roessler E, Belloni E, Gaudenz K, et al. Mutations in the human Sonic Hedgehog gene cause holoprosencephaly. Nat Genet 1996;14:357-60.
17. Bryden M, Evans H, Keeler R. Cyclopia in sheep caused by plant teratogens. J Anat 1971;110:507.
18. Cooper MK, Porter JA, Young KE, Beachey PA. Teratogen-mediated inhibition of target tissue response to Shh signaling. Science 1998;280:603-1607.
19. Chiang C, Litingtung Y, Lee E, et al. Cyclopia and defective axial patterning in mice lacking Sonic hedgehog gene function. Nature 1996;383:407-13.
20. Chen JK, Taipale J, Cooper MK, Beachey PA. Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened. Genes Dev 2002;16:2743-8.
21. Taipale J, Chen JK, Cooper MK, et al. Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine. Nature 2000;406:1005-9.
22. Chen JK, Taipale J, Young KE, Maiti T, Beachy PA. Small molecule modulation of Smoothened activity. Proc Natl Acad Sci U S A 2002;99:14071-6.
23. Robarge KD, Brunton SA, Castanedo GM, et al. GDC-0449 - A potent inhibitor of the hedgehog pathway. Bioorg Med Chem Lett 2009;19:5576-81.
24. Von Hoff DD, LoRusso PM, Rudin CM, et al. Inhibition of the Hedge-hog pathway in advanced basal-cell carcinoma. N Engl J Med 2009;361:1164-72.
25. Yauch RL, Dijkgraaf GJP, Alicke B, et al. Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma. Science 2009;326:572-4.
26. Siu LL, Papadopolous KP, Alberts SR, et al. A first-in-human phase 1 study of an oral hedgehog pathway antagonist, BMS-833923 (XL139), in subjects with advanced or metastatic solid tumors. Mol Cancer Ther 2009;8:A55.